Kenvue takeover speculation heats up ahead of M&A window
Kenvue Inc (NYSE:KVUE) is again at the center of takeover speculation as the August expiration of its post–spin-off tax agreement with…
17,900€
0,64%
Echtzeit-Aktienkurs Kenvue Inc.
Bid:
Ask:
Nachrichten zur Kenvue Inc. Aktie
Kenvue considering sale of skin and beauty brands to streamline portfolio: report
Kenvue Inc (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is considering selling a…
Kenvue stock climbs as second quarter comes in ahead of forecasts
Consumer brands firm Kenvue Inc (NYSE:KVUE) traded on the front foot in Thursday’s early deals, as its second quarter beat…
Kenvue, Inc. (KVUE) Q4 2024 Earnings Call Transcript
…
Kenvue Inc. 2024 Q3 - Results - Earnings Call Presentation
…
Tylenol maker Kenvue hails efficiency gains as activist Starboard watches on
Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just…
Kenvue gains on reports activist investor Starboard Value has taken ‘sizeable’ stake
Kenvue Inc (NYSE:KVUE) shares moved more than 6% higher on reports activist investor Starboard Value has taken a stake in…
Neuer Druck auf Kenvue: Starboard beteiligt sich und fordert Kurskorrektur
Der aktivistische Investor Starboard Value hat laut mit der Angelegenheit vertrauten Personen eine beträchtliche Beteiligung an Kenvue Inc. (NYSE:…
Kenvue Inc. (KVUE) Q2 2024 Earnings Call Transcript
…
Kenvue Inc. 2024 Q2 - Results - Earnings Call Presentation
…
Kenvue stock up 9% after earnings beat; consumer health stars
Shares in Kenvue Inc (NYSE:KVUE) were up 9% in pre-market trading after the company exceeded Wall Streets expectations for second-quarter profit and...…
Kenvue Inc. (KVUE) Q1 2024 Earnings Call Transcript
…
Kenvue shares rise on first quarter earnings beat
Kenvue Inc (NYSE:KVUE) shares moved higher after the Tylenol-maker posted better-than-expected first quarter earnings on Tuesday. Shares of the Johnson…
Kenvue Inc. declares $0.20 dividend
…
Neutrogena Is Closing Its Los Angeles Office and Laying Off Staff
Neutrogena is permanently closing its Los Angeles office as parent Kenvue Inc. consolidates operations to New Jersey.…